Biorestorative Therapies vs Clene
Biorestorative Therapies is the larger business, with $359,700 of revenue in fiscal 2025 against $200,000 for Clene (1.8 times as much). Biorestorative Therapies grew faster (-10.3% against -41.5%). Biorestorative Therapies kept more of each dollar of sales as profit: a net margin of -3959.4% against -13086.5%.
| Latest fiscal year | Biorestorative TherapiesBRTX, 2025 | CleneCLNN, 2025 |
|---|---|---|
| Revenue | $359,700 | $200,000 |
| Revenue growth | -10.3% | -41.5% |
| Net income | −$14.2m | −$26.2m |
| Operating margin | — | — |
| Net margin | -3959.4% | -13086.5% |
| Return on equity | — | — |
| Free cash flow | −$10.9m | −$18.6m |
| Cash | $1.5m | $5.2m |
| Total debt | $0 | $17.8m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $0 | — |
| Employees | 14 | 79 |
| Market value | $36.4m | $47.9m |
| Price vs our value range | — | — |
| Moat score | 17 (Weak) | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 62 sales |